Research Suggests Pharma Retains Lowest Share of Revenue than Other High R&D Industries
Oxford Economics in a new study suggests the pharmaceutical industry only retains 52 percent of total spending, with the remaining [...]
MSLS Webinar to Highlight Board Certification Program
The Medical Science Liaison Society (MSLS) is set to host a free webinar on the benefits of taking the MSL-Board [...]
Raman Offers Primer on U.S. Health System in New Book
Sivakumaran Raman in his latest book offers an overview of the U.S. health care system. "Just Enough Healthcare: A pick-up-and-read-through [...]
Report Spotlights Marketing During COVID-19
A new report from Reuters Events offers guidance for pharmaceutical industry solutions providers looking for fresh insights into marketing strategies [...]
ISPOR Seeks New Members for Health Science Policy Council
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is searching for three mid-career members for its Health Science Policy [...]
On-Demand Webinar Offers Guidance for Getting Started in MedComms
A recent webinar hosted by NetworkPharma.tv offers guidance for individuals interested in entering a career in the medical communications landscape. [...]
ICER Reschedules CF Meeting
The Institute for Clinical and Economic Review (ICER) has rescheduled its public meeting on cystic fibrosis treatments to Aug. 27. [...]
NICE Clinical Fellow Ali Highlights Sustainability Efforts
Fizzah Ali, a medical clinical fellow at the U.K.'s National Institute for Health and Care Excellence, discusses how the Sustainability [...]
ISPOR to Host Webinar on Drug, Device Utilization Amid Pandemic
The International Society for Pharmacoeconomics and Outcomes Research is set to host a July 28 webinar highlighting the COVID-19 pandemic's [...]
Report: European Drug Regulatory Network Faces Uncertain, Complex Future
A new strategy produced by European regulators considers future challenges for the European drug regulatory network, The Pink Sheet reports. [...]
ICER Outlines Planned Review of High Cholesterol Treatments
The Institute for Clinical and Economic Review (ICER) in a recently-released document outlines its planned review of high cholesterol treatments. [...]
NPC, Duke-Margolis Center for Health Policy Name New Health Policy Fellow
The National Pharmaceutical Council (NPC) and Duke-Margolis Center for Health Policy recently named Salama Freed as the 2020-22 post-doctoral health [...]
Cytel COVID-19 Clinical Development Quiz
Cytel is offering a quiz for users to gauge their knowledge on the state of COVID-19 clinical development across the [...]
OptumRx’s Calabrese: Top 3 Drugs in Pipeline
OptumRx Senior Vice President and Chief Pharmacy Officer David Calabrese in a recent interview with Managed Healthcare Executive discusses the [...]
McClellan Stresses Need for RWE Infrastructure
Duke-Margolis' Mark McClellan tells The Pink Sheet a robust real-world evidence infrastructure is needed, and that RWE studies should be [...]
Gupta: Five Trends That Have Accelerated in 2020
Heron Therapeutics' Anita Gupta in a recent piece published on Forbes highlights five key trends that have accelerated during the [...]
Evidation Looks to Bolster Platform to Include Virtual Treatment
After generating $45 million in investments, Evidation is looking to expand its virtual research platform to include digital interventions and [...]
ISPOR Short Course on Medical Devices is Tomorrow
The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) short course on market access and value assessment of medical devices [...]
Webinar on Future of Primary Care Set for July 28
World Congress is set to host a webinar July 28 on the future of primary care. The hour-long event, "The [...]
Blog Post Explores Key Issues in De-Implementation
The last installment of a four-part blog series by AcademyHealth's Research Community on Low-Value Care looks at some key hurdles [...]
Siami: NESTcc at ‘Pivot Point’
Sandra Siami, the new head of the National Evaluation System for health Technology Coordinating Center (NESTcc), tells MedTech Dive the [...]
Value & Outcomes Spotlight Editor-in-Chief Bids Farewell in Latest Issue
Value & Outcomes Spotlight Editor-in-Chief David Thompson bid readers farewell in the latest issue, describing his 12-plus years in the [...]
Gilead CEO: Remdesivir Priced ‘Significantly’ Below Value to Society
Gilead CEO Daniel O'Day told STAT he's confident in the company's pricing decision for the COVID-19 drug remdesivir. "We spent [...]
Healthcare Reimbursement Market to Reach $20 billion by 2025, Report Suggests
The U.S. healthcare reimbursement market could be valued at $20 billion by 2025, according to a new report by Brand [...]
Report: FDA Mandates 50% Efficacy for COVID-19 Vaccines
Vaccine candidates must be at least 50 percent more effective than a placebo to be considered for Food and Drug [...]